COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation
American Journal of Cardiovascular Drugs · 2024
DOI: 10.1007/s40256-024-00671-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Cardiovascular Drugs, 2024. Verfasst von Lanting Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmacy, University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, 9500 Gilman Dr, Room 2244, …. Hauptthemen laut MEDLINE: COVID-19, Atrial Fibrillation, Anticoagulants, Stroke. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, Pharmaceutical Research and Manufacturers of America Foundation.
Themen: Schlaganfall
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Clinical Pharmacy, University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, 9500 Gilman Dr, Room 2244, La Jolla, CA, 92093, USA.
- Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, FL, USA.
- Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
- Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.
- Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
- Center for the Study of Healthcare Innovation, Implementation and Policy, Greater Los Angeles VA Healthcare System, Los Angeles, CA, USA.
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- Pharmaceutical Research and Manufacturers of America Foundation
- National Heart, Lung, and Blood Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Yang, L., Tang, S., Guo, J., Gabriel, N., Gellad, W. F., Essien, U. R., Magnani, J. W., & Hernandez, I. (2024). COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation. American Journal of Cardiovascular Drugs. https://doi.org/10.1007/s40256-024-00671-3
Vancouver
Yang L, Tang S, Guo J, Gabriel N, Gellad WF, Essien UR, et al. COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation. American Journal of Cardiovascular Drugs. 2024. doi:10.1007/s40256-024-00671-3
BibTeX
@article{Yang2024,
author = {Yang, Lanting and Tang, Shangbin and Guo, Jingchuan and Gabriel, Nico and Gellad, Walid F and Essien, Utibe R and Magnani, Jared W and Hernandez, Inmaculada},
title = {COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation},
journal = {American Journal of Cardiovascular Drugs},
year = {2024},
doi = {10.1007/s40256-024-00671-3}
}
EUVIMED